Rituximab for Fatigue & Oral Dryness in Primary Sjögren’s Syndrome
Recommendations for Sjögren’s Syndrome: How to Address Biologics & Musculoskeletal Pain
Rheumatology Drug Updates: Giant Cell Arteritis Relapse Possible if Tocilizumab Discontinued; Plus Updates on Rituximab, Etanercept
Rituximab Promising for Dermatitis Herpetiformis
Malignancy Risk in ANCA-Associated Vasculitis Is Lower with Rituximab
FDA Update on Rituximab & Etanercept; Plus New ACP Gout Guideline
Reinitiating TNF Blockers after Tuberculosis Treatment
Remission of Rheumatoid Arthritis Tied to Lower Risk of Metabolic Syndrome
Roche & Novartis Face Off in Biosimilar Drug Battle
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- Next Page »